Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Overview of a yearly tax planning approach for index fund losses, detailing steps to track opportunities, document losses, and optimize filings.
19,474 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Palantir's chief technology officer raised alarms about U.S. weapon stock levels in a recent discussion, prompting re...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...
Behind every AI breakthrough lies a power backstop. This article explains how Vertiv quietly powering every AI data c...
With $1,000 in hand, your goal is steady income and growing wealth. This guide shows how to identify the ultimate div...
Intuitive Machines stock popped today as analysts weigh backlog, milestones, and funding signals. This article breaks...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
If SpaceX shifts a sizable slice of its IPO to everyday investors, the market could see bigger demand and new pricing...
Rumors swirl about SpaceX planning an IPO at a staggering $1.75 trillion. This article breaks down what that would me...